Elantas Beck India informs about outcome of board meeting

24 Jul 2018 Evaluate

Elantas Beck India has informed that the Board of Directors at its meeting held today i.e. 24 July 2018, has considered and approved the Un-audited Financial Results of the Company for the quarter and six months ended 30 June 2018. Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company submitted copy of the Un-audited Financial Results for the quarter and six months ended 30 June 2018, and Review Report. Further, pursuant to the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Board has appointed Stefan Genten as Alternate Director to Martin Babilas, Chairman of the Company.

The above information is a part of company’s filings submitted to BSE.

Elantas Beck India Share Price

8786.75 -148.20 (-1.66%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3635.80
Tata Chemicals 755.60
SRF 3025.85
Pidilite Inds. 1476.20
Deepak Nitrite 1547.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×